Marex Group plc (MRX) Stock Forecast
MRX analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.44 / 5 from 9 analysts
- Price target
- $81.88 average of analyst targets
- Upside to target
- +16.1% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $1.51
- 52-week range
- $30.20 – $78.27
MRX analyst ratings
9 analystsNumber of analysts at each rating.
MRX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MRX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.53 | $1.48 | $1.61 | $0.96 | +59.2% | 8 |
| Current fiscal year (2026) | $6.18 | $5.96 | $6.37 | $3.99 | +54.8% | 8 |
| Next fiscal year (2027) | $6.65 | $3.85 | $7.31 | $6.18 | +7.7% | 9 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MRX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $679.4M | $661.7M | $705.3M | +40.2% | 6 |
| Current fiscal year (2026) | $2.76B | $2.68B | $2.83B | +36.5% | 6 |
| Next fiscal year (2027) | $2.88B | $2.00B | $3.21B | +4.3% | 7 |
MRX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MRX revenue: reported and forecast
MRX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.23 | $1.50 | $1.50 | $1.53 | $1.53 | +24.4% | 3 up · 0 down |
| Current fiscal year (2026) | $5.16 | $6.13 | $6.13 | $6.18 | $6.18 | +19.6% | 3 up · 0 down |
| Next fiscal year (2027) | $5.77 | $6.39 | $6.39 | $6.57 | $6.65 | +15.3% | 4 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MRX earnings surprises
Reported EPS vs the consensus estimate for the last 10 quarters; MRX beat in 10 of 10.
What analysts expect from MRX
9 analysts cover Marex; their consensus rating is buy (4.44 on a 1–5 scale, where 5 is a strong buy). The average price target is $81.88, 16.1% above the latest close of $70.50. Analysts expect earnings of $6.18 per share for 2026, +54.8% from a year earlier. For 2027 the average estimate is $6.65 per share on revenue of $2.9 billion. Marex beat the EPS estimate in 10 of the last 10 quarters.
Related: MRX income statement, MRX key metrics, MRX chart. See the MRX stock overview for the latest quote and news.
MRX forecast FAQ
What is Marex's price target?
The average analyst price target for Marex is $81.88, 16.1% above the latest close of $70.50.
Is Marex a buy, hold or sell?
Of 9 analysts covering Marex, 5 rate it a strong buy, 3 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Marex's EPS forecast?
Analysts forecast $6.18 per share for 2026 (range $5.96 to $6.37); for 2027 the estimate is $6.65.
What is Marex's revenue forecast?
The average revenue estimate for 2026 is $2.8 billion, growth of 36.5%; for 2027 it is $2.9 billion.
When does Marex report earnings?
Marex is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $1.51.
Does Marex usually beat earnings estimates?
Marex reported EPS at or above the analyst estimate in 10 of the last 10 quarters.